Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 11Completed 11Active not recruiting 4Unknown 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 1Fatigue 1Depression 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Methylphenidate × Clear all
NCT03218254 2018-12-05

MICRO

Odense University Hospital

Phase 3 Unknown
150 enrolled

Fatigue

NCT01497548 2011-12-22

Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients

University of Malaya

Phase 3 Unknown
120 enrolled

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡